amlodipine and benazepril hydrochloride
Generic: amlodipine and benazepril hydrochloride
Labeler: northwind health company, llcDrug Facts
Product Profile
Brand Name
amlodipine and benazepril hydrochloride
Generic Name
amlodipine and benazepril hydrochloride
Labeler
northwind health company, llc
Dosage Form
CAPSULE
Routes
Active Ingredients
amlodipine besylate 10 mg/1, benazepril hydrochloride 20 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
51655-213
Product ID
51655-213_48d2a75b-7672-5a6d-e063-6294a90a18b8
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA202239
Listing Expiration
2027-12-31
Marketing Start
2022-10-20
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
51655213
Hyphenated Format
51655-213
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
amlodipine and benazepril hydrochloride (source: ndc)
Generic Name
amlodipine and benazepril hydrochloride (source: ndc)
Application Number
ANDA202239 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/1
- 20 mg/1
Packaging
- 90 CAPSULE in 1 BOTTLE, PLASTIC (51655-213-26)
- 30 CAPSULE in 1 BOTTLE, PLASTIC (51655-213-52)
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "48d2a75b-7672-5a6d-e063-6294a90a18b8", "openfda": {"unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898342"], "spl_set_id": ["f2b56630-4e3a-6f9c-e053-2a95a90a4650"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "90 CAPSULE in 1 BOTTLE, PLASTIC (51655-213-26)", "package_ndc": "51655-213-26", "marketing_start_date": "20221020"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE, PLASTIC (51655-213-52)", "package_ndc": "51655-213-52", "marketing_start_date": "20230502"}], "brand_name": "Amlodipine and Benazepril Hydrochloride", "product_id": "51655-213_48d2a75b-7672-5a6d-e063-6294a90a18b8", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "51655-213", "generic_name": "Amlodipine and Benazepril Hydrochloride", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine and Benazepril Hydrochloride", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "10 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "20 mg/1"}], "application_number": "ANDA202239", "marketing_category": "ANDA", "marketing_start_date": "20221020", "listing_expiration_date": "20271231"}